BWG Publications, Registration, Presentations and Publicity

Publications

Hamilton S, Bernstein AB, Blakey G, Fagan V, Farrow T, Jordan D, Seiler W, Gertel A, (the Budapest Working Group [BWG]). Critical Review of the TransCelerate Template for Clinical Study Reports (CSRs) and Publication of Version 2 of the CORE Reference (Clarity and Openness in Reporting: E3-based) Terminology Table. Research Integrity and Peer Review. 2019.                                                                                          http://dx.doi.org/10.1186/s41073-019-0075-5

Hamilton S, Bernstein AB, Blakey G, Fagan V, Farrow T, Jordan D, Seiler W, Shannon A, Gertel A, Budapest Working Group: Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trials transparency. Research Integrity and Peer Review. 2016.
http://researchintegrityjournal.biomedcentral.com/articles/10.1186/s41073-016-0009-4 and
http://dx.doi.org/10.1186/s41073-016-0009-4
Hamilton S, Seiler W, Gertel A: The EMWA Budapest Working Group: A 2-year collaboration to make recommendations for aligning the ICH E3 guidance with current practice and developing clinical study protocol guidance. Medical Writing 2014.
http://journal.emwa.org/post-approval-regulatory-writing/the-emwa-budapest-working-group-a-2-year-collaboration-to-make-recommendations-for-aligning-the-ich-e3-guideline-with-current-practice-and-developing-clinical-study-protocol-guidance/ and http://dx.doi.org/10.1179/2047480614Z.000000000254

Registration

CORE Reference is registered with http://www.equator-network.org as a 'reporting guideline’
http://www.equator-network.org/reporting-guidelines/core-reference/

Presentations

Gertel A, Hamilton S (planned presentation 08 May 2020, EMWA Prague conference cancelled). “Critical Review of the TransCelerate Template for Clinical Study Reports (CSRs) and Publication of Version 2 of the CORE Reference (Clarity and Openness in Reporting: E3-based) Terminology Table”.
Critical Review T/Cel CSR Template [Slide Deck]
Gertel A, Hamilton S (planned presentation 07 May 2020, EMWA Prague conference cancelled). “Docket # FDA-2019-N-2012. New Drugs Regulatory Program Modernization: Improving Approval Package Documentation and Communication”.
Docket # FDA-2019-N-2012 [Slide Deck]
Gertel A, Hamilton S (10 May 2019). “CORE Reference 3 Years On - A Resource for Continuing Professional Development”. Presentation including news of BWG review of the TransCelerate CSR template presented at the Regulatory Expert Seminar Series at the EMWA Conference in Vienna
CORE Reference - Three Years On [Slide Deck]
Bernstein A, Gertel A (26 June 2017). “The Core Reference Open Session” presented at the AMWA Conference in Rockville, Maryland, USA.
Ebina H, Fagan V, Gertel A (22 June 2017). Presentation (intermediate level session) at Drug Information Association (DIA) Annual Conference in Chicago, USA. "Driving International Awareness and Use of Regulatory Writing Guidelines: Case Studies of the Clarity and Openness in Reporting (CORE) Reference Guidelines". CORE Reference awareness: DIA 2017 [Slide Deck]
Hamilton S, Farrow T (04 May 2017). Presentation including Utility Survey Results. 5th EMWA Symposium, Birmingham, England.
CORE Reference - One Year On [Slide Deck]CORE Reference - One Year On [Symposium Report and Utility Survey Results]
Hamilton S (01 March 2017). “CORE Reference” [Half day presentation to The Danish Medical Writers Network, hosted by Leo Pharma in Copenhagen]
Bernstein A. (2016, July 17). CORE Reference: A Medical Writer’s Guide to Preparing CSRs in an Evolving Context [Webinar]. American Medical Writers Association Online Learning.
http://amwa.mycrowdwisdom.com/diweb/catalog/item/id/1165151/q/o=-d&c=185

In order to view the video, an AMWA login will need to be created. This is a free registration process for those who are not, or do not wish to become, AMWA members.

Hamilton S. Presentation. CORE Reference launch. Update to EMWA Conference, Munich. 12 May 2016
https://vimeo.com/167275242
Hamilton S, Farrow T, Fagan V, Gertel A, Blakey G. Presentation. CORE Reference. Project Update to EMWA Conference, The Hague. 06 November 2015.
https://vimeo.com/145279503
Gertel A, Bernstein A, Hamilton S. Presentation. CORE Reference. Project Update to EMWA Conference, Dublin. 06 May 2015.
https://vimeo.com/127467647

Publicity

Hamilton S, Jordan D. ‘CORE Reference - a tool for modern clinical study reports in an era of increasing transparency and disclosure’. Medical Writing 2018;27(2):64-67.
http://journal.emwa.org/public-disclosure/core-reference-a-tool-for-modern-clinical-study-reports-in-an-era-of-increasing-transparency-and-disclosure/
Hamilton S, Forjanic Klapproth J. ‘Streamlining clinical study protocols and reports’. Medical Writing: The Backbone of Clinical Development, Special Edition 2017: 28-31.
http://edition.pagesuite-professional.co.uk/launch.aspx?eid=f6b80f6a-ddd6-4705-bc9a-8af003f96adb
Hamilton S, Forjanic Klapproth J. ‘A new standard for medical writing’. WorldPharma Clinical Trials Insight 2016 (2):13-14.
http://viewer.zmags.com/publication/ad20d93c#/ad20d93c/13
PDF Downloadhttp://www.core-reference.org/media/1045/a-new-standard-for-medical-writing_sam-hamilton-and-julia-forjanic-klapproth_clinical-trials-insight_final.pdf
Sam Hamilton's BioMed Central Guest Blog ’Safeguarding the privacy of clinical trial patients’ 27 May 2016:
http://blogs.biomedcentral.com/on-medicine/2016/05/27/safeguarding-privacy-clinical-trial-patients/
Press release. CORE Reference launch. 03 May 2016
http://www.core-reference.org/media/1039/core-leaflet-a4.pdf
Press release. CORE Reference project plan. 28 January 2015
http://www.emwa.org/Documents/CORE%20Press%20Release-28jan15_final.pdf

Coming Soon

Regulatory Public Disclosure Special Interest Group - First "Meet and Share"

Join the discussion at the EMWA RPD SIG "Meet and Share"

Topics for discussion include two new requirements once the European Clinical Trials Regulation EU No 536/2014 becomes fully applicable: 1) lay person summaries of clinical trial results and 2) redaction of key clinical trial documents which will be made publicly available, e.g., protocol IB, CSR.

Where: Online (save the date for now; link will be shared when available) 

When: Friday 02 July 2021, 13.30-14.30 CET/12.30-13.30 BST

Third-party Publications and Presentations

The BWG, the developers of CORE Reference are pleased to share the following third-party materials about CORE Reference. The BWG does not accept responsibility for the accuracy of third-party materials. If you have a third-party publication to share, please email: contact@core-reference.org

The TransCelerate Biopharma Clinical Study Report template (December 2019 release) is available on the TransCelerate website under:Clinical Content and Reuse Assets

ICH E3 and CORE Reference are the two “well-known standards” used in TransCelerate’s CSR template development in this TransCelerate slide deck.

Note: The developers of CORE Reference were not involved in TransCelerate’s CSR template development.

CORE Reference-related updates are now available in Japanese on a dedicated blog. Thank you to Yukie Uchiyama (responsible for Japanese writing of the blog) and Hiroko Ebina (responsible for quality assurance of the blog) for making this initiative possible.

Note: The opinions expressed in Yukie Uchiyama’s blog, and the interpretations of CORE Reference are solely those of the blogger, and are not necessarily those of the CORE Reference authors.

Ebina H, Homma Y, Woolley KL. Poster P-11 (English translation from the Japanese): CORE Reference: New guidelines of preparing clinical study reports for Japanese biopharmaceutical companies seeking international regulatory approvals. Presented at the 6th General Meeting for the Society of Regulatory Science of Medical Products. 9-10 September 2016, Tokyo, Japan.
http://www.core-reference.org/media/1044/ebina-homma-woolley_englishtranslation-japanposter-29aug16.pdf

Radkova E. Slide presentation. Clarity and Openness in Reporting: E3-based (CORE) Reference. OCT IV Annual Conference - Clinical Trials in and Outside Russia. 19 September 2016, Moscow, Russia.
http://www.core-reference.org/media/1043/eradkova-oct-conference-russia-19sep2016.pdf